Vanguard Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $324M | Sell |
|
|||||
|
2025
Q2 | $329M | Buy |
|
|||||
|
2025
Q1 | $253M | Buy |
|
|||||
|
2024
Q4 | $256M | Buy |
|
|||||
|
2024
Q3 | $213M | Buy |
|
|||||
|
2024
Q2 | $223M | Buy |
|
|||||
|
2024
Q1 | $246M | Sell |
|
|||||
|
2023
Q4 | $419M | Sell |
|
|||||
|
2023
Q3 | $284M | Sell |
|
|||||
|
2023
Q2 | $332M | Buy |
|
|||||
|
2023
Q1 | $257M | Buy |
|
|||||
|
2022
Q4 | $211M | Buy |
|
|||||
|
2022
Q3 | $211M | Buy |
|
|||||
|
2022
Q2 | $175M | Sell |
|
|||||
|
2022
Q1 | $305M | Buy |
|
|||||
|
2021
Q4 | $287M | Buy |
|
|||||
|
2021
Q3 | $201M | Buy |
|
|||||
|
2021
Q2 | $281M | Buy |
|
|||||
|
2021
Q1 | $280M | Buy |
|
|||||
|
2020
Q4 | $567M | Buy |
|
|||||
|
2020
Q3 | $428M | Sell |
|
|||||
|
2020
Q2 | $517M | Sell |
|
|||||
|
2020
Q1 | $464M | Buy |
|
|||||
|
2019
Q4 | $454M | Buy |
|
|||||
|
2019
Q3 | $378M | Buy |
|
|||||
|
2019
Q2 | $254M | Buy |
|
|||||
|
2019
Q1 | $255M | Sell |
|
|||||
|
2018
Q4 | $164M | Buy |
|
|||||
|
2018
Q3 | $183M | Buy |
|
|||||
|
2018
Q2 | $132M | Buy |
|
|||||
|
2018
Q1 | $183M | Buy |
|
|||||
|
2017
Q4 | $240M | Buy |
|
|||||
|
2017
Q3 | $293M | Buy |
|
|||||
|
2017
Q2 | $212M | Buy |
|
|||||
|
2017
Q1 | $257M | Buy |
|
|||||
|
2016
Q4 | $205M | Buy |
|
|||||
|
2016
Q3 | $219M | Buy |
|
|||||
|
2016
Q2 | $207M | Buy |
|
|||||
|
2016
Q1 | $177M | Buy |
|
|||||
|
2015
Q4 | $200M | Buy |
|
|||||
|
2015
Q3 | $180M | Buy |
|
|||||
|
2015
Q2 | $222M | Buy |
|
|||||
|
2015
Q1 | $167M | Buy |
|
|||||
|
2014
Q4 | $155M | Buy |
|
|||||
|
2014
Q3 | $120M | Buy |
|
|||||
|
2014
Q2 | $109M | Buy |
|
|||||
|
2014
Q1 | $117M | Buy |
|
|||||
|
2013
Q4 | $108M | Buy |
|
|||||
|
2013
Q3 | $107M | Buy |
|
|||||
|
2013
Q2 | $53M | Buy |
|